Tin tức & Cập nhật

Original New Drug Application Approvals by US FDA (01 - 15 June 2022)

15 Jun 2022

New drug applications approved by US FDA as of 01 - 15 June 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 June 2022)

15 Jun 2022

Venetoclax boosts HRQoL in AML patients unfit for intensive chemotherapy

14 Jun 2022

Drug combinations including venetoclax seem to have a positive impact on health-related quality of life (HRQoL), or at least does not worsen it, in patients with acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy, a recent study has found.

Venetoclax boosts HRQoL in AML patients unfit for intensive chemotherapy

14 Jun 2022

‘Digital Twin’ tech reverses type 2 diabetes, fixes metabolic disruptions

14 Jun 2022 bởi

A novel artificial intelligence platform that integrates multidimensional data to deliver precision nutrition and health recommendations not only helps to induce remission in type 2 diabetes but also to normalize a range of glycaemic and extraglycaemic parameters, as shown in a study presented at the 82nd American Diabetes Association (ADA) Scientific Sessions.

‘Digital Twin’ tech reverses type 2 diabetes, fixes metabolic disruptions

14 Jun 2022

Orthostatic hypotension ups mortality risk in geriatric outpatients

14 Jun 2022

Older outpatients with delayed/prolonged orthostatic hypotension (DPOH) are at higher risk of mortality, reveals a study. The magnitude of both systolic and diastolic OH is also associated with increased death.

Orthostatic hypotension ups mortality risk in geriatric outpatients

14 Jun 2022

Cancer patients report high acceptance of telemedicine

14 Jun 2022 bởi

Patients with cancer are not averse to telemedicine, reporting satisfaction with their experience, according to a Singapore study. This high acceptance is associated with facilitating conditions such as having necessary resources and perceived improved access.

Cancer patients report high acceptance of telemedicine

14 Jun 2022

Beta-blocker use reduces daily physical activity

14 Jun 2022

Treatment with beta-blockers in hypertension may decrease daily physical activity but not maximal exercise performance, a study has found.

Beta-blocker use reduces daily physical activity

14 Jun 2022

Higher dairy intake tied to lower T2D risk

14 Jun 2022 bởi

Higher consumption of dairy products is associated with a lower risk of type 2 diabetes (T2D) among US adults, according to a nationally representative study presented at ADA 2022.

Higher dairy intake tied to lower T2D risk

14 Jun 2022

Autoantibodies against type 1 interferons increase COVID-19 death risk

14 Jun 2022 bởi

The presence of autoantibodies neutralizing type 1 interferons (IFN), such as IFN-α2 or IFN-ω, strongly increase the relative risk of death (RRD) and infection fatality rate (IFR) in unvaccinated patients with COVID-19, according to a recent study.

Autoantibodies against type 1 interferons increase COVID-19 death risk

14 Jun 2022

Playing a musical instrument boosts brain blood flow

14 Jun 2022

For musicians, playing a musical instrument appears to increase blood flow velocity in the middle cerebral artery (MCAv), a recent study has found.

Playing a musical instrument boosts brain blood flow

14 Jun 2022

Amiodarone use may reduce survival in continuous‐flow left ventricular assist device recipients

14 Jun 2022

For patients who have undergone continuous‐flow left ventricular assist device (CF‐LVAD) implantation, treatment with amiodarone may do more harm than good, with a recent study showing that it contributes to increased risk of mortality.

Amiodarone use may reduce survival in continuous‐flow left ventricular assist device recipients

14 Jun 2022

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Original New Drug Application Approvals by US FDA (01 - 15 June 2022)

Original New Drug Application Approvals by US FDA (01 - 15 June 2022)

Venetoclax boosts HRQoL in AML patients unfit for intensive chemotherapy

Venetoclax boosts HRQoL in AML patients unfit for intensive chemotherapy

‘Digital Twin’ tech reverses type 2 diabetes, fixes metabolic disruptions

‘Digital Twin’ tech reverses type 2 diabetes, fixes metabolic disruptions

Orthostatic hypotension ups mortality risk in geriatric outpatients

Orthostatic hypotension ups mortality risk in geriatric outpatients

Cancer patients report high acceptance of telemedicine

Cancer patients report high acceptance of telemedicine

Beta-blocker use reduces daily physical activity

Beta-blocker use reduces daily physical activity

Higher dairy intake tied to lower T2D risk

Higher dairy intake tied to lower T2D risk

Autoantibodies against type 1 interferons increase COVID-19 death risk

Autoantibodies against type 1 interferons increase COVID-19 death risk

Playing a musical instrument boosts brain blood flow

Playing a musical instrument boosts brain blood flow

Amiodarone use may reduce survival in continuous‐flow left ventricular assist device recipients

Amiodarone use may reduce survival in continuous‐flow left ventricular assist device recipients